Citations

Showing 10 of 108094 citations.

Medical and Semi-surgical Treatments for Fuchs Endothelial Corneal Dystrophy
Wacker, Katrin , Baratz, Keith H. , Fautsch, Michael P. , Patel, Sanjay V.

Mayo Clinic

Klinische Monatsblätter für Augenheilkunde | May 3, 2018 | Volume: 235 | Issue: 06 | Pages: 709-713

10.1055/a-0577-7953 | PMID 29723889 Get It

AbstractUnraveling the genetic mechanisms of Fuchs endothelial corneal dystrophy has opened new possibilities for future targeted medical therapy of the disease. Until these possibilities mature, regenerative semi-surgical approaches by cell injection or cell sheet transfer could help expand the donor pool, and possibly enable autologous transplantation. Descemet membrane stripping alone and acellular Descemet membrane transfer are more immediate surgical approaches that could be temporary treatments in some patients, though there is a lack of understanding of the factors that predict success for these procedures. Regardless of approach, clinical trials will be necessary, and clinicians should therefore try to standardize their methods of assessing disease severity and the outcomes of intervention.
Are Results of Arthroscopic Labral Repair Durable in Dysplasia at Midterm Follow-up? A 2-Center Matched Cohort Analysis
Hartigan, David E. , Wu, Isabella T. , Levy, Bruce A. , Domb, Benjamin G. , Krych, Aaron J. , Krych, Aaron J , Hevesi, Mario

Mayo Clinic

The American Journal of Sports Medicine | May 3, 2018 | Volume: 46 | Issue: 7 | Pages: 1674-1684

10.1177/0363546518767399 | PMID 29723044 Get It

Background: Studies assessing dysplasia’s effect on hip arthroscopy are often limited to the short term and unable to account for demographic factors that may vary between dysplastic and nondysplastic populations. Purpose: To determine the midterm failure rate and patient-reported outcomes of arthroscopic labral repair in the setting of dysplasia and make subsequent failure and outcome comparisons with a rigorously matched nondysplastic control group. Study Design: Cohort study; Level of evidence, 3. Methods: Primary arthroscopic labral repair cases at 2 centers from 2008 to 2011 were reviewed. Patients with lateral center edge angle (LCEA) <25° were matched to nondysplastic controls by age, sex, laterality, body mass index (BMI), Tönnis grade, and capsular repair per a 1:2 matching algorithm. Groups were compared with a visual analog scale (VAS) for pain, modified Harris Hip Score (mHHS), and Hip Outcome Score–Sports Specific Subscale (HOS-SSS) to determine predictors of outcome and failure. Results: Forty-eight patients with dysplasia (mean LCEA, 21.6°; range, 13.0°-24.9°; n = 25 with capsular repair) were matched to 96 controls (mean LCEA, 32.1°; range, 25°-52°; n = 50 with capsular repair) and followed for a mean of 5.7 years (range, 5.0-7.7 years). Patients achieved mean VAS improvements of 3.3 points, mHHS of 19.5, and HOS-SSS of 29.0 points ( P < .01) with no significant differences between the dysplasia and control populations ( P > .05). Five-year failure-free survival was 83.3% for patients with dysplasia and 78.1% for controls ( P = .53). No survival or outcomes difference was observed between patients with dysplasia who did or did not have capsular repair ( P ≥ .45) or when comparing LCEA <20° and LCEA 20° to 25° ( P ≥ .60). BMI ≤30 was associated with increased revision surgery risk ( P < .01). Age >35 years ( P < .05) and Tönnis grade 0 radiographs ( P < .01) predicted failure to reach minimal clinically important differences. Conclusion: With careful selection and modern techniques, patients with dysplasia can benefit significantly and durably from arthroscopic labral repair. The dysplastic cohort had outcomes and failure rates similar to those of rigorously matched controls at midterm follow-up. Subanalyses comparing LCEA <20° and LCEA 20° to 25° are presented for completeness; however, this study was not designed to detect differences in dysplastic subpopulations. BMI ≤30 was associated with increased revision risk. Age >35 years and Tönnis grade 0 radiographs predicted failure to achieve minimal clinically important differences.
Elevated extracellular potassium prior to muscle contraction reduces onset and steady-state exercise hyperemia in humans
Terwoord, Janée D. , Luckasen, Gary J. , Richards, Jennifer C., Hearon, Christopher M. , Joyner, Michael J. , Dinenno, Frank A.

Mayo Clinic

Journal of Applied Physiology | May 3, 2018 | Volume: 125 | Issue: 2 | Pages: 615-623

10.1152/japplphysiol.00183.2018 | PMID 29722620 Get It

The increase in interstitial potassium (K+) during muscle contractions is thought to be a vasodilatory signal that contributes to exercise hyperemia. To determine the role of extracellular K+in exercise hyperemia, we perfused skeletal muscle with K+before contractions, such that the effect of any endogenously-released K+would be minimized. We tested the hypothesis that local, intra-arterial infusion of potassium chloride (KCl) at rest would impair vasodilation in response to subsequent rhythmic handgrip exercise in humans. In 11 young adults, we determined forearm blood flow (FBF) (Doppler ultrasound) and forearm vascular conductance (FVC) (FBF/mean arterial pressure) during 4 min of rhythmic handgrip exercise at 10% of maximal voluntary contraction during 1) control conditions, 2) infusion of KCl before the initiation of exercise, and 3) infusion of sodium nitroprusside (SNP) as a control vasodilator. Infusion of KCl or SNP elevated resting FVC similarly before the onset of exercise (control: 39 ± 6 vs. KCl: 81 ± 12 and SNP: 82 ± 13 ml·min−1·100 mmHg−1; both P < 0.05 vs. control). Infusion of KCl at rest diminished the hyperemic (ΔFBF) and vasodilatory (ΔFVC) response to subsequent exercise by 22 ± 5% and 30 ± 5%, respectively (both P < 0.05 vs. control), whereas SNP did not affect the change in FBF ( P = 0.74 vs. control) or FVC ( P = 0.61 vs. control) from rest to steady-state exercise. These findings implicate the K+ion as an essential vasodilator substance contributing to exercise hyperemia in humans.NEW & NOTEWORTHY Our findings support a significant and obligatory role for potassium signaling in the local vasodilatory and hyperemic response to exercise in humans.
Improving collaboration between primary care and mental health services
Kates, Nick , Currie, Elizabeth , Hanlon, Charlotte , Gask, Linda , Klasen, Henrikje, Meadows, Graham , Rukundo, Godfrey Zari , Sunderji, Nadiya , Williams, Mark D. , Williams, Mark, Arroll, Bruce , Ruud, Torleif

Mayo Clinic

The World Journal of Biological Psychiatry | May 3, 2018 | Volume: 20 | Issue: 10 | Pages: 748-765

10.1080/15622975.2018.1471218 | PMID 29722600 Get It

EGFRvIII–Stat5 Signaling Enhances Glioblastoma Cell Migration and Survival
Roos, Alison , Peng, Sen, Inge, Landon J. , Tuncali, Serdar, Pineda, Michael , Millard, Nghia , Mayo, Zachary, Eschbacher, Jennifer , Loftus, Joseph C. , Winkles, Jeffrey A. , Tran, Nhan L. , Pineda, Michael , Winkles, Jeffrey A , Dhruv, Harshil , Tran, Nhan L

Mayo Clinic

Molecular Cancer Research | May 3, 2018 | Volume: 16 | Issue: 7 | Pages: 1185-1195

10.1158/1541-7786.mcr-18-0125 | PMID 29724813 Get It

Abstract Glioblastoma multiforme (GBM) is the most common brain malignancies in adults. Most GBM patients succumb to the disease less than 1 year after diagnosis due to the highly invasive nature of the tumor, which prevents complete surgical resection and gives rise to tumor recurrence. The invasive phenotype also confers radioresistant and chemoresistant properties to the tumor cells; therefore, there is a critical need to develop new therapeutics that target drivers of GBM invasion. Amplification of EGFR is observed in over 50% of GBM tumors, of which half concurrently overexpress the variant EGFRvIII, and expression of both receptors confers a worse prognosis. EGFR and EGFRvIII cooperate to promote tumor progression and invasion, in part, through activation of the Stat signaling pathway. Here, it is reported that EGFRvIII activates Stat5 and GBM invasion by inducing the expression of a previously established mediator of glioma cell invasion and survival: fibroblast growth factor-inducible 14 (Fn14). EGFRvIII-mediated induction of Fn14 expression is Stat5 dependent and requires activation of Src, whereas EGFR regulation of Fn14 is dependent upon Src–MEK/ERK–Stat3 activation. Notably, treatment of EGFRvIII-expressing GBM cells with the FDA-approved Stat5 inhibitor pimozide blocked Stat5 phosphorylation, Fn14 expression, and cell migration and survival. Because EGFR inhibitors display limited therapeutic efficacy in GBM patients, the EGFRvIII–Stat5–Fn14 signaling pathway represents a node of vulnerability in the invasive GBM cell populations. Implications: Targeting critical effectors in the EGFRvIII–Stat5–Fn14 pathway may limit GBM tumor dispersion, mitigate therapeutic resistance, and increase survival. Mol Cancer Res; 16(7); 1185–95. ©2018 AACR.
Modified Glanulopexy Technique for Supersonic Transporter Deformity and Glanular Hypermobility in Men With Penile Prostheses
Ziegelmann, Matthew , Alom, Manaf, Bole, Raevti , Köhler, Tobias , Trost, Landon , Ziegelmann, Matthew J

Mayo Clinic

The Journal of Sexual Medicine | May 3, 2018 | Volume: 15 | Issue: 6 | Pages: 914-919

10.1016/j.jsxm.2018.04.633 | PMID 29731427 Get It

Abstract Background Glanular hypermobility (GH) or supersonic transporter (SST) deformity are occasionally encountered during penile prosthesis (PP) implantation, yet management strategies are underreported with minimal data available on surgical outcomes. Aim To describe a modified technique for glanulopexy to correct GH/SST in men undergoing PP placement and assess outcomes associated with this technique. Methods Glanulopexy was performed in men with GH/SST identified at the time of or following PP placement. A modification to previously described techniques was performed, whereby a suture is passed into the glans and secured to the tissue overlying the corpora through small incisions on the lateral aspects of the distal penile shaft. Outcomes Correction of the anatomic deformity (GH/SST), device infection, and changes in penile sensation were evaluated during post-operative follow-up. Results From 2014–2017, a total of 12 patients underwent modified glanulopexy for GH/SST. Nine (75%) were performed at the time of PP, while the remaining 3 were performed in a delayed fashion. At a median follow-up of 12 months (range 1–33 months), all patients with the device in situ demonstrated appropriate glanular positioning, and no patients reported changes in penile sensation. A single patient required device removal secondary to infection. Clinical Translation Glanulopexy with permanent suture successfully corrects severe GH or SST in men with inflatable PP without reduced penile sensation. Conclusions Strengths of the current study include the description of a simple, safe, and reproducible technique for GH/SST that adds minimal operative time and can be performed under local anesthesia when necessary. To our knowledge, this represents one of the largest reported series of glanulopexy outcomes reported in the literature. Limitations include that this is a single-surgeon series, there is limited follow-up, and lack of a comparison group. Further study with external validation is warranted to establish the optimal role for the procedure.
The 14th International Workshops on Opportunistic Protists (IWOP 14)
Cushion, Melanie T. , Porollo, Aleksey , Saper, Vivian E , Sinai, Anthony P. , Weiss, Louis M. , Limper, Andrew H.

Mayo Clinic

Journal of Eukaryotic Microbiology | May 3, 2018 | Volume: 65 | Issue: 6 | Pages: 934-939

10.1111/jeu.12631 | PMID 29722096 Get It

AbstractThe 14th International Workshops on Opportunistic Protists (IWOP‐14) was held August 10–12, 2017 in Cincinnati, OH, USA. The IWOP meetings focus on opportunistic protists (OIs); for example, free‐living amoebae, Pneumocystis spp., Cryptosporidium spp., Toxoplasma, the Microsporidia, and kinetoplastid flagellates. The highlights of Pneumocystis spp. research included the reports of primary homothallism for mating; a potential requirement for sexual replication in its life cycle; a new antigen on the surface of small asci; roles for CLRs, Dectin‐1, and Mincle in host responses; and identification of MSG families and mechanisms used for surface variation. Studies of Cryptosporidia spp. included comparative genomics, a new cryopreservation method; the role of mucin in attachment and invasion, and epidemiological surveys illustrating species diversity in animals. One of the five identified proteins in the polar tube of Microsporidia, PTP4, was shown to play a role in host infection. Zebrafish were used as a low cost vertebrate animal model for an evaluation of potential anti‐toxoplasma drugs. Folk medicine compounds with anti‐toxoplasma activity were presented, and reports on the chronic toxoplasma infection provided evidence for increased tractability for the study of this difficult life cycle stage. Escape from the parasitophorus vacuole and cell cycle regulation were the topics of the study in the acute phase.
GWAS4D: multidimensional analysis of context-specific regulatory variant for human complex diseases and traits
Huang, Dandan , Yi, Xianfu , Zhang, Shijie , Zheng, Zhanye, Wang, Panwen , Sham, Pak C. , Wang, Junwen , Li, Mulin Jun , Wang, Junwen , Xuan, Chenghao

Mayo Clinic

Nucleic Acids Research | May 3, 2018 | Volume: 46 | Issue: W1 | Pages: W114-W120

10.1093/nar/gky407 | PMID 29771388 Get It

Reproducibility of gastric emptying assessed with scintigraphy in patients with upper GI symptoms
Desai, Anshuman, O’Connor, Michael K. , Neja, Bridget, Delaney, K , Camilleri, Michael , Zinsmeister, A. R., Bharucha, Adil E. , Camilleri, M , Bharucha, A E

Mayo Clinic

Neurogastroenterology & Motility | May 3, 2018 | Volume: 30 | Issue: 10 | Pages: No page available

10.1111/nmo.13365 | PMID 29722126 Get It

AbstractBackgroundThe reproducibility of gastric emptying (GE) measured with scintigraphy in patients is poorly understood. Our aims were to assess the intra and inter‐individual reproducibility of these parameters in patients with upper gastrointestinal symptoms.MethodsSixty patients (21 diabetics, 39 non‐diabetics) with upper gastrointestinal symptoms underwent scintigraphic‐assessment of GE of a solid meal (296 kcal, 30% fat) over 4 hours on two occasions at an average interval of 15 days. The concordance correlation coefficient (CCC), intra and inter‐individual coefficients of variation (COV) of GE endpoints were analyzed.ResultsThe GE t1/2 was 134 ± 8 minutes (mean ± SEM) for the first and 128 ± 6 minutes for the second study. The mean (95% CI) CCC between the two studies was 0.79 (0.67, 0.87) for GE at 1 hour, 0.83 (0.75, 0.9) for GE at 2 hours, 0.54 (0.34, 0.7) for GE at 4 hours, and 0.79 (0.68, 0.86) for GE t1/2. However, in 18 of 60 patients (30%), the characterization of GE as normal, delayed, or rapid differed between the first and second studies. For gastric empting t1/2, the inter‐individual coefficients of variation was 40%; the intra‐individual COV was 20%, comparable in diabetics and non‐diabetics, and greater in patients with rapid (28%) than delayed (18%) or normal GE (12%).Conclusions & InferencesAmong patients with upper gastrointestinal symptoms, GE measured with scintigraphy is relatively reproducible. In 30% of cases, the interpretation was different between the two assessments. Hence, a diagnosis of gastroparesis based on a single study may occasionally be inaccurate.
Some Suggestions for Practice in Infant Adoptions
Kohlsaat, Barbara, Johnson, Adelaide M., KOHLSAAT, BARBARA

Mayo Clinic

Social Casework | May 3, 2018 | Volume: 35 | Issue: 3 | Pages: 91-99

10.1177/104438945403500301 Get It